Last Updated:
COVID-19: When Can Pregnant Women In India Get Vaccinated? Top Medical Experts Answer FAQs
Republic Media Network posed some common FAQs to leading medical practitioners Dr Achana Bajaj and Dr Nandita Palshetkar on vaccines for pregnant women.
RepublicTV
As India is currently witnessing its phase 3 of the COVID-19 inoculation, yet pregnant women population has not been included in the drive. Countries like the US, UK and China have started vaccinating pregnant women and lactating mothers. However, India is yet to immunize this section of the population. Republic Media Network posed some common FAQs to leading medical practitioners Dr Achana Bajaj, Obstetrician-gynecologist and Dr Nandita Palshetkar, Ex-president of Obstetrician-gynaecological society of India & Consultant in Leelavati Hospital, Mumbai on vaccines for pregnant women.
India made two crucial changes to its Covid treatment protocol, both were prompted by the research done in the UK and published in the reputed medical journal The Lancet .
Serum Institute of India is producing Covishield vaccine in India in partnership with AstraZeneca.
As per a report submitted by the National AEFI (Adverse Event Following Immunization) Committee to the Ministry of Health & Family Welfare, more than 23,000 adverse events were reported through the CO-WIN platform reported from 684 of the 753 districts of the country. Of these, only 700 cases (@ 9.3 cases /million doses administered) were reported to be serious and severe nature the report said. 26 cases have been reported to be potential thromboembolic (formation of a clot in a blood vessel that might also break loose and carried by the blood stream to plug another vessel) events – following the administration of Covishield vaccine – with a reporting rate of 0.61 cases/ million doses, said the committee.
URL copied Image Source : PTI
A health worker administers a dose of Covishield vaccine to the citizens at a hospital in Dharavi in Mumbai.
Bleeding and clotting cases following COVID-19 vaccination in India are minuscule and in line with the expected number of diagnoses of these conditions in the country, a report submitted by the National AEFI (Adverse Event Following Immunization) Committee to the Ministry of Health & Family Welfare said.
Alerts have been raised in some countries on post-vaccination embolic and thrombotic events on 11 March, 2021 particularly with AstraZeneca-Oxford vaccine (Covishield in India). A decision was taken to conduct an urgent in-depth analysis of the adverse events (AE) in India in light of the global concerns.
‘Bleeding and clotting cases minuscule in India’
May 17, 2021
Over 23,000 adverse events reported after India launched the vaccination drive
Bleeding and clotting cases following Covid vaccination in India are minuscule and in line with the expected number of diagnoses of these conditions in the country, said a report submitted by the National AEFI (Adverse Event Following Immunisation) Committee to the Ministry of Health & Family Welfare.
In-depth analysis
In its report, the committee said that alerts have been raised in some countries on post-vaccination “embolic and thrombotic events”, particularly with the AstraZeneca-Oxford vaccine, Covishield, in India. A decision was taken to conduct an urgent in-depth analysis of the adverse events in India in the light of the global concerns.